DE3325506A1 - Salbe - Google Patents

Salbe

Info

Publication number
DE3325506A1
DE3325506A1 DE19833325506 DE3325506A DE3325506A1 DE 3325506 A1 DE3325506 A1 DE 3325506A1 DE 19833325506 DE19833325506 DE 19833325506 DE 3325506 A DE3325506 A DE 3325506A DE 3325506 A1 DE3325506 A1 DE 3325506A1
Authority
DE
Germany
Prior art keywords
ointment
pain
substance
gramicidin
neomycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19833325506
Other languages
English (en)
Inventor
Manfred 7700 Singen Reichle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19833325506 priority Critical patent/DE3325506A1/de
Publication of DE3325506A1 publication Critical patent/DE3325506A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  • Salbe Die Erfindung betrifft eine Substanz zur Schmerzlinderungt bei Erweiterung der Mastdarmblutadern.
  • Für derartige Anwendungen sind Zäpfchen bekannt, welche durch die Körpertemperatur anschmelzen und so einen salbenartigen Überzug auf den genannten Erweiterungen bilden.
  • Der Erfinder hat sich das Ziel gesetzt, eine besonders günstige Substanz für den genannten Anwendungszweck zu schaffen, die ohne Schmerzen den zu behandelnden Stellen zugeführt werden kann.
  • Zur Lösung dieser Aufgabe führt eine antibiotikahaltige Salbe, die je Gramm etwa 2,50 mg Neomycin, 1,00 mg Triamcinolonacetonid, 0,25 mg Gramicidin, Rest reizarme salbenartige Zusätze, enthält; die Verwendung dieses Kortikoids bringt nach Erkenntnis des Erfinders hervorragende Ergebnisse bei der schmerzlindernden Behandlung der bekanntlich bislang nur unzulänglich zu mildernden Erweiterungen der Mastdarmblutader.

Claims (1)

  1. P A T E N T A N 5 P R U C H Substanz zur Sobmerzlinderung bei Erweiterung der Mastdarmblutadern, gekennzeichnet durch eine antibiotikahaltige Salbe, die je Gramm etwa 2,50 mg Neomycin, 1,00 mg Triamcinolonacetonid, 0,25 mg Gramicidin, Rest reizarme salbenartige Zusätze, enthält
DE19833325506 1983-07-15 1983-07-15 Salbe Withdrawn DE3325506A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19833325506 DE3325506A1 (de) 1983-07-15 1983-07-15 Salbe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833325506 DE3325506A1 (de) 1983-07-15 1983-07-15 Salbe

Publications (1)

Publication Number Publication Date
DE3325506A1 true DE3325506A1 (de) 1985-01-24

Family

ID=6204016

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833325506 Withdrawn DE3325506A1 (de) 1983-07-15 1983-07-15 Salbe

Country Status (1)

Country Link
DE (1) DE3325506A1 (de)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022983A1 (en) * 1994-02-24 1995-08-31 Ddr Enterprises Incorporated Topical composition for the treatment of aphthous ulcers containing an antimicrobial agent and a corticosteroid
EP0693932A1 (de) * 1993-03-19 1996-01-31 Cellegy Pharmaceuticals, Inc. Verfahren und zusammensetzung zur induktion der phasentrennung der lipiddoppelschicht von epithelzellen
US6562606B1 (en) 1993-03-19 2003-05-13 The Regents Of The University Of California Methods and compositions for disrupting the epithelial barrier function
EP1750772A1 (de) * 2004-05-14 2007-02-14 Universite Laval Phospholipase-c-gamma-modulation und ihre verwendung zur behandlung von schmerzen und nozizeption
US7709207B2 (en) 2003-05-16 2010-05-04 Universite Laval Method for identifying compounds for treatment of pain

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0693932A1 (de) * 1993-03-19 1996-01-31 Cellegy Pharmaceuticals, Inc. Verfahren und zusammensetzung zur induktion der phasentrennung der lipiddoppelschicht von epithelzellen
EP0693932A4 (de) * 1993-03-19 2000-06-14 Cellegy Pharma Inc Verfahren und zusammensetzung zur induktion der phasentrennung der lipiddoppelschicht von epithelzellen
US6562606B1 (en) 1993-03-19 2003-05-13 The Regents Of The University Of California Methods and compositions for disrupting the epithelial barrier function
WO1995022983A1 (en) * 1994-02-24 1995-08-31 Ddr Enterprises Incorporated Topical composition for the treatment of aphthous ulcers containing an antimicrobial agent and a corticosteroid
US7709207B2 (en) 2003-05-16 2010-05-04 Universite Laval Method for identifying compounds for treatment of pain
US8173376B2 (en) 2003-05-16 2012-05-08 Universite Laval Method for identifying compounds for treatment of pain
EP1750772A1 (de) * 2004-05-14 2007-02-14 Universite Laval Phospholipase-c-gamma-modulation und ihre verwendung zur behandlung von schmerzen und nozizeption
EP1750772A4 (de) * 2004-05-14 2009-09-09 Univ Laval Phospholipase-c-gamma-modulation und ihre verwendung zur behandlung von schmerzen und nozizeption
US7718382B2 (en) 2004-05-14 2010-05-18 Universite Laval Method for identifying compounds for treatment of pain

Similar Documents

Publication Publication Date Title
Malmo et al. Electromyographic studies of muscular tension in psychiatric patients under stress.
IL91322A0 (en) Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
ATE79761T1 (de) Behandlung einer krankheit vom aids-typ.
DE3325506A1 (de) Salbe
Kissin The production of pain in exercising skeletal muscle during induced anoxemia
Djupesland Intra-Aural Muscular Reflexes Elicited by Air Current Stimulation of the External Ear: Preliminary Report
PH12964A (en) Pyranochromone derivatives and therapeutic composition comprising same for treatment of allergic diseases
EP0279867A3 (de) Verwendung von Vitamin-E und Vitamin-E-Kombination mit nichtsteroidalen Antirheumatika und Schmerzmittel zur Behandlung von rheumatischen Erkrankungen
Tsushima Treatment of phantom limb pain with EMG and temperature biofeedback: A case study.
Lebo et al. The influence of instructional set upon the discomfort-relief quotient.
Hunt Psychological issues in the preoperative preparation of open heart surgery patients.
Ladisich et al. Sensitivity to stress in the premenstruum and the effect of progestogen substitution
福島龍也 STUDIES ON PURE TONE AUDIOMETRY FOR YOUNGER CHILDREN
Heggö Tendinitis calcarea supraspinati: 41 operated cases
EP0253083A3 (en) Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment
Heckmann et al. Zur Physiologie der Irisstrombahn
Khumar et al. A study of therapeutic effect of GSR biofeed-back on mild hypertension.
EP0198321A1 (de) Einen Plasminogenaktivator enthaltendes Mittel
Becker et al. 179. Indikation, Technik und Ergebnisse der femoro-femoralen Umleitung
SU624604A1 (ru) Входной каскад усилител кардиомонитора
Kochubey Main trends in cognitive psychophysiology
Weller 67. Die posttraumatische und postoperative Frühinfektion nach offenen und geschlossenen Knochenbrüchen—Einführung in das Thema
Arnauld et al. Non-invasive assessment of cardiotoxic effects of cytostatic agents.- Investigations with respect to ADM-containing chemotherapy-.
Van Allen A COMPARISON OF RELAXATION AND COGNITIVE TRAINING PROCEDURES IN THE TREATMENT OF TENSION HEADACHE.
Hassler Media Fibrosis of Human Cerebral Arteries

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee